DiaSorin S.p.A. (DIA) — Stock analysis
EURCurrent price
66,60 €
-0,20 € (-0.30%) today
Market signals
About DiaSorin S.p.A.
DiaSorin is an Italian in-vitro diagnostics (IVD) company specialising in immunodiagnostics and molecular diagnostics. It makes instruments and diagnostic kits for clinical laboratories, with applications in infectious diseases, oncology, cardiology and metabolism. In 2021 it acquired Luminex, strengthening the molecular segment. Operates in over 60 countries. Headquartered in Saluggia (Vercelli).
What does DiaSorin do?▾
DiaSorin makes diagnostic kits and instruments for clinical laboratories. Tests cover infectious diseases, oncology, endocrinology and metabolism. Since 2021, with the Luminex acquisition, it significantly expanded molecular diagnostics capability (PCR, hybridisation).
Which exchange is DiaSorin listed on?▾
DiaSorin is listed on Borsa Italiana with ticker DIA. It is a member of the FTSE MIB index.
Does DiaSorin pay dividends?▾
Yes. It distributes a modest annual dividend. Yield is typically 0.5–1%.
Analyse this stock with AI
Create a free account and get 2 credits to generate a complete analysis.
Create account · 2 free credits